An international network of researchers announced the release of a new web-based resource designed to facilitate the development of medicines to fight infectious diseases afflicting the developing world.
Merck KGaA announced the conclusion of a ten-year partnership with WHO to control schistosomiasis in African schoolchildren. For this purpose, Merck will provide for free 200 million tablets Cesol? 600 (active ingredient praziquantel) with a value of approximately US$ 80 million.
Electronic mosquito repellents ? buzzing devices marketed to prevent malaria ? don’t prevent bites and therefore don?t prevent disease transmission, according to a new review of studies.
Johns Hopkins University researchers have cured malaria-infected mice with single shots of a new series of potent, long lasting synthetic drugs modeled on an ancient Chinese herbal folk remedy.
Alarmed over incidents of dreaded bird flu in some neighbouring countries, the Indian government said it has issued an alert to states bordering the affected countries to keep a vigil on the poultry sector.
As a week-long meeting of health ministers organised by the African U nion (AU) got underway in Johannesburg on Monday, AIDS activists expressed concern that commitments on HIV/AIDS, tuberculosis and malaria, reached at several meetings last year, were missing from the agenda.
Roll Back Malaria, the global partnership to fight malaria, launched a campaign to improve the quality of proposals from sub-Saharan African countries to the Global Fund.
Cancer researchers estimate that the number of cancer cases will more than double over the next 25 years, with the great majority of the increase in developing countries.
The Institute for OneWorld Health, a US-based non-profit pharmaceutical company that develops drugs for people with neglected diseases in the developing world, today announced the selection of Odyssey Research, a Bismarck, North Dakota-based clinical trial management organization (TMO) with offices in New Delhi, India, to support its upcoming Phase 4 pharmacovigilance and access study of Paromomycin Intramuscular (IM) Injection for the treatment of visceral leishmaniasis (VL) in India.
A BMA report brings good news and bad news for the millions of people suffering from ?neglected diseases? in the developing world.